834 related articles for article (PubMed ID: 8497891)
1. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms.
Hancock WW; DiStefano R; Braun P; Schweizer RT; Tilney NL; Kupiec-Weglinski JW
Transplantation; 1990 Feb; 49(2):416-21. PubMed ID: 2106180
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen.
Sayegh MH; Zhang ZJ; Hancock WW; Kwok CA; Carpenter CB; Weiner HL
Transplantation; 1992 Jan; 53(1):163-6. PubMed ID: 1733066
[TBL] [Abstract][Full Text] [Related]
4. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
[TBL] [Abstract][Full Text] [Related]
5. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
6. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH
J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337
[TBL] [Abstract][Full Text] [Related]
7. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
[TBL] [Abstract][Full Text] [Related]
8. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
Arima T; Lehmann M; Flye MW
Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
[TBL] [Abstract][Full Text] [Related]
9. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
Hancock WW; Sayegh MH; Sablinski T; Kut JP; Kupiec-Weglinski JW; Milford EL
Transplantation; 1992 Jun; 53(6):1276-80. PubMed ID: 1604485
[TBL] [Abstract][Full Text] [Related]
10. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
Salom RN; Maguire JA; Hancock WW
Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
[TBL] [Abstract][Full Text] [Related]
12. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
[TBL] [Abstract][Full Text] [Related]
13. alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines.
Heidecke CD; Hancock WW; Westerholt S; Sewczik T; Jakobs F; Zantl N; Varzaru A; Siegling A; Kurrle R; Deusch K; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(6):948-56. PubMed ID: 8623165
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
[TBL] [Abstract][Full Text] [Related]
15. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
[TBL] [Abstract][Full Text] [Related]
16. Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression.
Coito AJ; Korom S; Graser E; Volk HD; Van De Water L; Kupiec-Weglinski JW
Transplantation; 1998 Mar; 65(5):699-706. PubMed ID: 9521206
[TBL] [Abstract][Full Text] [Related]
17. In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4.
Hancock WW; Sayegh MH; Carpenter CB
Transplant Proc; 1992 Oct; 24(5):2313-4. PubMed ID: 1413074
[No Abstract] [Full Text] [Related]
18. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
Binder J; Hancock WW; Watschinger B; Wasowska B; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1995 Feb; 59(4):590-7. PubMed ID: 7878763
[TBL] [Abstract][Full Text] [Related]
19. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
[TBL] [Abstract][Full Text] [Related]
20. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
